(Q36331865)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Helena Canhão

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Ana Maria Rodrigues

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Joaquim Polido Pereira

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Catia Duarte

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

José Antonio da Silva

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Fernando Pimentel-Santos

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jaime Branco

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

João E. Fonseca

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

18

Elizabeth W Karlson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

20

Daniel H Solomon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

5

Fernando Martins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

4

Ana Filipa Mourão

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Hélde Araujo Domingos

11

object named as

Domingos Araújo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

José Canas-Silva

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

José Alberto Pereira Silva

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

José António Costa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Cândida Silva

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Helena Santos

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Maria José Santos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

28 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

2020-2026

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

9 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

Tumor necrosis factor inhibitors: clinical implications of their different immunogenicity profiles

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide D

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

The central role of the propensity score in observational studies for causal effects

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES184

Reuma.pt - the rheumatic diseases portuguese register

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

Portuguese guidelines for the use of biological agents in rheumatoid arthritis - March 2010 update

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3475979

Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

21 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES184

Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study

21 January 2018

1 reference

12 December 2020

Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register

1 reference

12 December 2020

Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic "matrix design"

1 reference

12 December 2020

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

12 December 2020

10.1093/RHEUMATOLOGY/KES184

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

PubMed publication ID

22843791

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843791%20AND%20SRC:MED&resulttype=core&format=json